Global regulatory bodies are increasingly developing policies with direct impacts on the digital health market. To date, however, there has been very limited consideration of evidence in these policy discussions. We advise and advocate for domestic and international policies that are soundly based in evidence, prioritize the safety of patient health data, and are appropriate for low-income populations.